Trending Now
Sanofi SA (NASDAQ:SNY) and GlaxoSmithKline plc (NYSE:GSK) Announce the First-in-Human Trial...
Threats from the Covid-19 pandemic are large enough. This calls for multiple types of approaches in the development of a potential vaccine. A few...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
What to expect from Charles Schwab (NYSE:SCHW) earnings
In the last trading session, SCHW stock traded at $50.77, experiencing a decrease of $0.72, which represents a 1.40% drop in value....
MAKE IT MODERN
LATEST REVIEWS
Invesco QQQ stock hopes for a delayed Santa Rally
Invesco QQQ stock is currently trading at 266.26-0.50 (-0.19%). After shaking out dip buyers and those hoping for a Santa Rally yesterday the...
MAKE IT MODERN
PERFORMANCE TRAINING
Outlook Therapeutics Inc. (NASDAQ: OTLK) Presents NORSE II ONS-5010 Study Data At AAO 2021...
Outlook Therapeutics Inc. (NASDAQ: OTLK) has presented vital efficacy and safety data from the third phase NORSE Two ONS-5010 study. ONS-5010 is an experimental...
Clover Biopharmaceuticals Commences Study On COVID-19 Vaccine Using Dynavax Technologies’ (NASDAQ:DVAX) CpG 1018 Adjuvant
Dynavax Technologies Corporation (NASDAQ:DVAX) has announced that the first subjects have been doses in the first phase clinical study evaluating Clover Biopharmaceuticals' COVID-19 vaccine...
Curis, Inc. (NASDAQ: CRIS) Will Present Data on Its TakeAim Leukaemia and TakeAim Lymphoma...
Curis, Inc. (NASDAQ: CRIS) has announced that it will present encouraging data from its TakeAim Leukaemia and TakeAim Lymphoma trials at the American Society...
Could it be Time for Watch Stocks? (MOV, FOSL, CLKA, TIF)
The pandemic has decimated certain market segments. And much of this destruction may be overdone, especially given rapid progress on vaccine and monoclonal antibody...
Selecta Biosciences Inc (NASDAQ:SELB) Will Advance Gene Therapy Program In H1 2021 In MMA:...
Selecta Biosciences Inc (NASDAQ:SELB) posts a loss of $24.1 million in Q2 2020. Its general and administrative expenses in Q2 2020 are $5.6 million,...
MAKE IT MODERN
